[3H]BrdUrd-substituted DNA pcrobes were prepared from organ cultures of differentiating chicken neural retina and cell cultures of stage 24 chicken limb buds. Reassociation reactions using the neural retina probe demonstrated amplification of DNA sequences during differentiation of neural retina. This robe a so contained sequences present in greater numbers inheart DNA than in DNA from undifferentiated neural retina. Reassociation reactions of both differentiated cartilage and differentiated neural retina DNA with both the neural retina probe and the cartilage probe demonstrated that at least part of the amplified sequences are tissue specif- cess nonradioactive DNAs prepared from embryonic tissues and cultures at various stages of chondrogenesis. The genomes of chondrocytes obtained from limb bud cultures or embryonic sternae contain more probe-complementary sequences than do the genomes of noncartilage cells (liver, brain, and heart), stage 24 limb bud mesenchymal cells, or cells of limb bud cultures that had been irreversibly inhibited from differentiation by BrdUrd (4). Buoyant density analyses indicated that the BrdUrd residues were incorporated in clusters by the limb bud mesenchymal cells during the first 2 days of culture (4). It was proposed that, in the chicken embryo, chondrogenic determination is accompanied by amplification of DNA sequences. In the presence of 32 ,M BrdUrd, these sequences become highly substituted with the analogue and are subsequently degraded. Therefore, these BrdUrd-treated cells are temporally past the critical time for chondrogenic determination but lack the amplified sequences necessary for the expression of the cartilage phenotype and differentiation is irreversibly blocked.
tiated neural retina. Reassociation reactions of both differentiated cartilage and differentiated neural retina DNA with both the neural retina probe and the cartilage probe demonstrated that at least part of the amplified sequences are tissue specific.
Limb bud mesenchymal cells from stage 24 chicken embryos differentiate into chondrocytes when cultured at confluent densities. If the dThd analogue BrdUrd is present at a concentration of 32 uM during the initial 48 hr of culture, chondrogenic differentiation is irreversibly blocked (1, 2) . Previous experiments revealed that [3H]BrdUrd was preferentially incorporated into moderately repetitive DNA sequences by stage 24 limb bud mesenchymal cells grown for the initial 48 hr at confluent density in the presence of 32 uM BrdUrd. The [3H]BrdUrd was subsequently excised from the genome at the rate of 23% per day (3) .
A radioactive DNA probe, isolated from limb bud cells cultured in the presence of 32 MM BrdUrd and [3H]BrdUrd (33 MlCi/ml) for 48 hr, was used in reassociation reactions with excess nonradioactive DNAs prepared from embryonic tissues and cultures at various stages of chondrogenesis. The genomes of chondrocytes obtained from limb bud cultures or embryonic sternae contain more probe-complementary sequences than do the genomes of noncartilage cells (liver, brain, and heart), stage 24 limb bud mesenchymal cells, or cells of limb bud cultures that had been irreversibly inhibited from differentiation by BrdUrd (4). Buoyant density analyses indicated that the BrdUrd residues were incorporated in clusters by the limb bud mesenchymal cells during the first 2 days of culture (4) . It was proposed that, in the chicken embryo, chondrogenic determination is accompanied by amplification of DNA sequences. In the presence of 32 ,M BrdUrd, these sequences become highly substituted with the analogue and are subsequently degraded. Therefore, these BrdUrd-treated cells are temporally past the critical time for chondrogenic determination but lack the amplified sequences necessary for the expression of the cartilage phenotype and differentiation is irreversibly blocked.
Neural retina tissue from early chicken embryos differentiates in vitro (5, 6) . In 5-day embryos, the neural retina consists of a simple neuroepithelium; during 5 days in organ culture, its development continues and the tissue acquires a retinotypic histological organization. It also acquires competence, within 3 days of culture, for induction of glutamine synthetase by hydrocortisone. Onset of this competence and the induction of glutamine synthetase are characteristic markers of neuroretina differentiation. If retinae isolated from 5-day embryos are treated with BrdUrd (50 ,uM) for 20 hr, their morphological and biochemical differentiations are drastically altered. Instead of acquiring a retinotypic histological architecture, the cells become reproducibly disorganized and the development of competence for glutamine synthetase induction is almost entirely and irreversibly blocked (5, 6) .
MATERIALS AND METHODS Tissue Culture. Culture of stage 24 limb bud mesenchyme at high density was carried out as described (3, 4) . Five-day neural retinae were removed and organ cultured in rotating flasks as described in detail elsewhere (5, 6) .
Preparation of Driver DNA. Nonradioactive DNA was prepared as described (3, 4) from 8-day confluent-density limb bud cultures, 17-day embryonic hearts, 5-day neural retinae, 12-day neural retinae that had been organ-cultured for 24 hr with hydrocortisone, and 19-day neural retinae (5) . Briefly, the procedure consisted of homogenization of tissue, extraction with phenol and chloroform/isoamyl alcohol, and digestion with RNase. The DNA preparations were sheared by ultrasonic treatment to 5-6 S as determined by neutral linear sucrose gradients (3, 4) . Preparation of Radioactive Probes. A partially purified cartilage probe was isolated from confluent limb bud cultures incubated for the initial 48 hr with 32 ,gM BrdUrd and [3H]-BrdUrd (33 ,Ci/ml). The DNA was purified and centrifuged to equilibrium in neutral CsCl gradients. All material banding at buoyant densities corresponding to greater than 35% substitution of dThd residues by BrdUrd (7) was collected, sheared, and freed from fold-back DNA. This probe had a specific activity of 2.79 X 107 cpm/mg of DNA. This fraction was enhanced for cartilage-specific-amplified sequences (unpublished data).
Five-day neural retinae were dissected and organ-cultured for 20 hr in the presence of 50MM BrdUrd and [3H]BrdUrd (33 MiCi/ml). The cells were lysed and the DNA was isolated as described above. The two neural retina preparations of probe had specific activities of 2.95 and 6.07 X 107 cpm/mg of DNA, respectively. Shearing and the removal of fold-back DNA were carried out as described (3, 4) . Approximately 8% of the total radioactivity of these probes was removed as fold-back DNA by boiling and hydroxyapatite chromatography.
Reassociation Analysis. Reassociation mixtures contained Abbreviations: Cot, product of nucleotide concentration (mol/liter) and time (sec); Cotita, Cot value at which one-third of the radioactivity is double stranded. 4451
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Proc. Natl. Acad. Sci. USA 75 (1978) 100-to 150-fold excess of sheared nonradioactive DNA with respect to sheared radioactive probe. Aliquots were sealed in disposable micropipettes, boiled for 5 min, and incubated at 650. Periodically, tubes were withdrawn, cooled in an ice-water bath, and frozen until analyzed by hydroxyapatite chromatography as described (3, 4) . The parameters Cot [product of concentration of nucleotides (mol/liter) and time (sec)] and Cot1/3 (Cot value at which one-third of the radioactivity is double stranded) were determined and linear regression analyses were carried out as described (3, 4) . For differences reported as significant, P < 0.05. RESULTS Reassociation of Neural Retina Probe with Undifferentiated and Differentiated Neural Retina DNAs. The DNAs of both differentiated and undifferentiated neural retina were used in 150-fold excess to drive the reassociation of neural retina probe. Fig. 1 as well as cartilage-specific-amplified sequences (4) . Additional studies using partially purified cartilage probe have confirmed these observations (unpublished data). To determine whether neural retina probe also contained sequences not specific for retina, reassociation reactions were carried out with neural retina probe and heart DNA. Fig. 2 compares the reassociations of 12-day differentiated neural retina DNA and heart DNA with neural retina probe. The heart DNA drove the reassociation of neural retina probe at a significantly 1.8-fold slower rate <Cotj/3 = 630) than did the differentiated neural retina DNA. This rate, although slower than that of differentiated neural retina DNA, was nonetheless significantly faster (2.0-fold) than that of undifferentiated neural retina DNA. The neural retina probe contains sequences that are present in greater numbers in mature cardiac cells than in undifferentiated neural retina cells.
Reassociation of Cartilage and Neural Retina Probes with Differentiated Cartilage and Neural Retina DNAs. Because amplification coincident with differentiation had been observed in two different chicken tissues, it became of interest to determine the tissue specificity of the amplified sequences. The reassociation kinetics of the cartilage and neural retina probes with both sternal cartilage DNA and neural retina DNA were examined. Figs. 3 and 4 show the results of these experiments using the same preparations of probes and two preparations of each driver. The neural retina DNA drove the reassociation of neural retina probe at a 2.0-fold faster rate (COt113 = 354) than did sternal cartilage DNA (COtl/3 = 707) (Fig. 3) but drove the reassociation of cartilage probe at a 2.0-fold slower rate (Cot1/3 = 891) than did sternal cartilage DNA (Cot1/3 = 446) (Fig. 4 ).
These data demonstrate that different specific DNA sequences 10o- 
DISCUSSION
In the present study, a [3H]BrdUrd-labeled DNA probe was prepared from developing neural retina cells and used to demonstrate an amplification of DNA sequences during chicken neural retina differentiation. The neural retina probe and the partially purified cartilage probe were prepared by incubating cultures of undifferentiated cells in BrdUrd and [3H]BrdUrd at concentrations and for durations sufficient to irreversibly inhibit subsequent in vitro differentiation.
Differentiated neural retina DNA from 12-day neural retinae drove the reassociation of neural retina probe at a 3.6-fold faster rate than did undifferentiated neural retina DNA. In contrast, differentiated cartilage DNA drove the reassociation of cartilage probe at a 2.0-fold faster rate than did undifferentiated cartilage DNA (4) . There are at least two possible explanations for this difference. It should first be noted that the observed difference in rates is a function of at least two variables: the actual amplification number and the purity of the probe. For a constant amplification number, the observed difference in rates will become greater with increasing purity of the probe. The observation of a 3.6-fold difference during neural retina differentiation and a 2.0-fold difference during cartilage differentiation may result from the presence of more nonspecific DNA sequences in the cartilage probe than in the neural retina probe or an actual difference in amplification frequencies between the two tissues. (12) have demonstrated that at least 80% of the unique sequences of sea urchin DNA are contiguous to moderately repetitive DNA. The sequences amplified during chicken cartilage and neural retina differentiation may be regulatory, functioning to "turn on" the synthesis of differentiation-specific genes. Another possibility is that the amplified sequences represent structural genes. Alt et al. (13) have recently demonstrated the amplification of a structural gene in cultured murine cells. The purification of messenger RNAs for differentiation-specific proteins will be necessary to test this hypothesis. The observations in this study and those previously published suggest specific modification of genomes during cytodifferentiation.
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